Calico Life Sciences LLC

KineMed Inc. is a leading biotech company based in Emeryville, CA, dedicated to accelerating drug development by collaborating with major pharmaceutical and biotechnology firms. Founded by inventor Marc Hellerstein in 2001, the company focuses on pathway-based drug discovery and development, offering data on target engagement, toxicity, and disease progression to optimize the process and reduce associated risks. Specializing in real-time insights into conditions such as metabolic disorders, cancer, and neurodegenerative diseases, KineMed enables the identification of active drug candidates preclinically and confirms their therapeutic efficacy. The company has played a significant role in expediting the drug development process, underscoring its commitment to innovation in medical diagnostics and therapeutics. Generated from the website

SciGene Corporation, located in Santa Clara, CA, specializes in innovative solutions for fluorescence in situ hybridization (FISH) and karyotyping applications. Their product lineup includes advanced systems such as the Scorpion Robot, MicroFISH System, and various FISH reagents designed to enhance laboratory efficiency and accuracy. In addition to their core products, SciGene offers essential tools like the Hybex Incubator and Little Dipper Processor, along with a range of supportive materials including wash buffers and stabilizing agents. The company is committed to providing comprehensive technical support and resources to ensure optimal use of their products in scientific research. Generated from the website

SomaGenics develops and provides novel RNA-based gene inhibitors for functional genomics and therapeutics. The company specializes in tools and technologies for drug discovery. It researches inflammatory and autoimmune disorders, HIV and hepatitis C. SomaGenics' primary platform technology is a gene-targeting approach called the RNA Lasso. RNA Lassos have potential applications in drug target discovery, therapeutics, research, and diagnostics. The RNA Lasso platform technology provides a significant advance in addressing diagnostics for research, agricultural, veterinary, food, and medical testing, as well as drug development and discovery. In addition to therapeutic development, SomaGenics has several technology applications available for licensing with partners. The company is based in Santa Cruz, Calif.